During the past decade, Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher" are "COVID-19" (2 trials), "SARS (Disease)" (1 trials), "SARS-CoV-2 Acute Respiratory Disease" (1 trials), "SARS-CoV-2 Infection" (1 trials) and "SARS-CoV2 Infection" (1 trials). Many other conditions were trialed in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher" in a lesser frequency.

Most popular intervention types in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher" are "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "BNT162b2" (2 trials), "BNT162b1" (1 trials), "BNT162b2 (B.1.1.529)" (1 trials), "BNT162b2 (B.1.1.7 + B.1.617.2)" (1 trials) and "BNT162b2 (B.1.1.7)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Brinkum Dr. Lars Pohlmeier und Torsten Drescher, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".